STOCK TITAN
  1. Home
  2. News
  3. HZNP

Horizon Therapeutics plc to Present at the Cowen and Company 41st Annual Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following conference in March:

Cowen and Company 41st Annual Health Care Conference (Virtual)

  • Date: Tuesday, Mar. 2, 2021
  • Presentation Time: 1:30 p.m. ET

The conference presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizontherapeutics.com. A replay of the webcast will be available following the event.

About Horizon

Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, please visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.

Stock HZNP logo
Horizon Therapeutics Plc

NASDAQ:HZNP

HZNP Rankings

N/A Ranked by Market Cap
#180 Ranked by Stock Gains
N/A Ranked by Dividends

HZNP Latest News

Oct 6, 2023
Rule 17(e) Announcement - Horizon Therapeutics plc
Oct 5, 2023
Rule 17(d) Announcement – Horizon Therapeutics plc
Oct 3, 2023
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
Oct 2, 2023
Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023
Sep 29, 2023
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)

HZNP Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Health Technology, Pharmaceuticals: Other, Manufacturing, Pharmaceutical Preparation Manufacturing

About HZNP

at horizon therapeutics, we believe science and compassion must work together to transform lives. we are driven to deliver innovative medicines to those living with rare, autoimmune and severe inflammatory diseases because we uniquely understand the patient journey. for us, success is measured by the numbers that matter most – the number of lives we touch, the number we change and those we work to help save.